Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$0.75 - $1.1 $9,423 - $13,820
-12,564 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$0.96 - $1.74 $12,061 - $21,861
12,564 New
12,564 $13,000
Q3 2019

Nov 14, 2019

SELL
$0.59 - $0.9 $31,506 - $48,060
-53,400 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$0.79 - $1.11 $35,471 - $49,839
-44,900 Reduced 45.68%
53,400 $46,000
Q1 2019

May 15, 2019

BUY
$0.6 - $1.41 $58,980 - $138,603
98,300 New
98,300 $107,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.